Biogen Inc
Change company Symbol lookup
Select an option...
BIIB Biogen Inc
PWR Quanta Services Inc
NTWK NetSol Technologies Inc
WSNAF Wesana Health Holdings Inc
ZEUS Olympic Steel Inc
EJH E-Home Household Service Holdings Ltd
AMZN Amazon.com Inc
BGTTF Goat Industries Ltd
BRDS Bird Global Inc
GHM Graham Corp
Go

Health Care : Biotechnology | Large Cap Value
Company profile

Biogen Inc. is a global biotechnology company. The Company is focused on discovering, developing and delivering therapies for people living with serious and complex diseases worldwide. It has a portfolio of medicines to treat multiple sclerosis (MS), spinal muscular atrophy (SMA) and Alzheimer's disease. It is focused on advancing its pipeline in neurology, neuropsychiatry, specialized immunology and rare diseases. Its marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS; SPINRAZA for the treatment of SMA; ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. It is also advancing its mid-to-late stage programs, including zuranolone for major depressive disorder (MDD) and postpartum depression (PPD), BIIB080 for Alzheimer's disease, tofersen for amyotrophic lateral sclerosis (ALS) and both litifilimab and dapirolizumab pegol for certain forms of lupus.

Price
Delayed
$271.99
Day's Change
1.96 (0.73%)
Bid
--
Ask
--
B/A Size
--
Day's High
272.43
Day's Low
270.12
Volume
(Light)

Today's volume of 38,831 shares is on pace to be much lighter than BIIB's 10-day average volume of 919,376 shares.

38,831
  • Prev Close
    270.03
  • Today's Open
    270.81
  • Day's Range
    270.12-272.43
  • Avg Vol (10-day)
    919.4K
  • Last (time)
    9:47a ET 03/27/23
  • Last (size)
    100
  • 52-Wk Range
    187.16 - 311.88
    LowHigh
  • (05/09/22 - 11/30/22)
    12.79%
  • 44.7%
  • Market Cap
    39.3B
  • Shares Outstanding
    144.5M
  • --
  • --x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • --
  • --

Latest News

March 24, 2023
4:40 pm ET
MarketWatch
March 23, 2023
4:41 pm ET
MarketWatch
March 22, 2023
6:28 pm ET
MarketWatch
4:41 pm ET
MarketWatch
3:25 pm ET
MarketWatch
March 21, 2023
4:40 pm ET
MarketWatch
March 20, 2023
4:41 pm ET
MarketWatch
March 17, 2023
4:41 pm ET
MarketWatch
March 16, 2023
4:41 pm ET
MarketWatch
March 15, 2023
4:41 pm ET
MarketWatch
March 14, 2023
8:34 pm ET
MarketWatch
8:58 am ET
MarketWatch
March 13, 2023
4:41 pm ET
MarketWatch
March 10, 2023
4:41 pm ET
MarketWatch
5:20 am ET
Zacks
March 09, 2023
4:40 pm ET
MarketWatch
March 08, 2023
4:40 pm ET
MarketWatch
7:30 am ET
Globe Newswire
6:30 am ET
BusinessWire
March 07, 2023
4:41 pm ET
MarketWatch
March 06, 2023
4:40 pm ET
MarketWatch
March 05, 2023
6:30 pm ET
PR Newswire
6:30 pm ET
Globe Newswire
March 03, 2023
4:41 pm ET
MarketWatch
March 02, 2023
4:40 pm ET
MarketWatch
March 01, 2023
4:41 pm ET
MarketWatch
February 28, 2023
4:41 pm ET
MarketWatch
February 27, 2023
6:30 pm ET
PR Newswire
6:30 pm ET
Globe Newswire
4:40 pm ET
MarketWatch
February 24, 2023
4:40 pm ET
MarketWatch
February 23, 2023
4:40 pm ET
MarketWatch
February 22, 2023
4:40 pm ET
MarketWatch
February 21, 2023
4:41 pm ET
MarketWatch
2:21 pm ET
Zacks
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.